Drug Profile
Pegylated somatropin - Novo Nordisk
Alternative Names: NNC-126-0083; Pegylated recombinant human growth hormone - Novo Nordisk; Pegylated rhGH - Novo NordiskLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Novo Nordisk
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Somatotropin deficiency
Most Recent Events
- 05 Jul 2012 Discontinued - Phase-I for Somatotropin deficiency in Germany (SC)
- 05 Jul 2012 Discontinued - Phase-II for Somatotropin deficiency in Belgium, Czech Republic, Denmark, France, Israel, Macedonia, Slovenia, Spain, Turkey and United Kingdom(SC)